Autor segons l'article: Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A, RARECAREnet Working Group
Departament: Medicina i Cirurgia
Autor/s de la URV: Galceran Padrós, Jaume Josep Maria
Paraules clau: Testicular neoplasms Tertiary care centres Survival Squamous cell Rare diseases Penis neoplasms Neoplasms Germ cell and embryonal Europe Community network Carcinoma tertiary care centres survival squamous cell rare diseases penis neoplasms neoplasms germ cell and embryonal europe community network carcinoma
Resum: © 2018 Germ-cell tumours (GCT) of the testis and penile squamous cell carcinoma (PeSCC) are a rare and a very rare uro-genital cancers, respectively. Both tumours are well defined entities in terms of management, where specific recommendations - in the form of continuously up-to-dated guide lines-are provided. Impact of these tumour is relevant. Testicular GCT affects young, healthy men at the beginning of their adult life. PeSCC affects older men, but a proportion of these patients are young and the personal consequences of the disease may be devastating. Deviation from recommended management may be a reason of a significant prognostic worsening, as proper treatment favourably impacts on these tumours, dramatically on GCT and significantly on PeSCC. RARECAREnet data may permit to analyse how survivals may vary according to geographical areas, histology and age, leading to assume that non-homogeneous health-care resources may impact the cure and definitive outcomes. In support of this hypothesis, some epidemiologic datasets and clinical findings would indicate that survival may improve when appropriate treatments are delivered, linked to a different accessibility to the best health institutions, as a consequence of geographical, cultural and economic barriers. Finally, strong clues based on epidemiological and clinical data support the hypothesis that treatment delivered at reference centres or under the aegis of a qualified multi-institutional network is associated with a better prognosis of patients with these malignancies. The ERN EURACAN represents the best current European effort to answer this clinical need.
Àrees temàtiques: Surgery Oncology Medicine (miscellaneous) Medicina iii Medicina ii Medicina i General medicine Enfermagem
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 07487983
Adreça de correu electrònic de l'autor: jaumejosepmaria.galceran@urv.cat
Data d'alta del registre: 2023-02-18
Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
Enllaç font original: https://www.ejso.com/article/S0748-7983(18)30416-5/fulltext
Referència a l'article segons font original: Ejso. 45 (1): 60-66
Referència de l'ítem segons les normes APA: Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A, RARECAREnet Working Group (2019). Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Ejso, 45(1), 60-66. DOI: 10.1016/j.ejso.2018.02.006
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
DOI de l'article: 10.1016/j.ejso.2018.02.006
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2019
Tipus de publicació: Journal Publications